SC Filed 2021-03-26 Event — SEC 0000947871-21-000394 →

ORBIMED ADVISORS LLC → GRAYBUG VISION, INC. CALC

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

6 13D/G filings on this issuer

5 other filings besides this one

Filer Track Record

139 filings by this filer

138 other filings in the data moat

Short Interest · settle 2026-07-31

DTC 1.81

503,070 shares short · -47.6% vs prior

Other 13D/G Filings on GRAYBUG VISION, INC.

Filed	Form	Filer	Stake	Shares
2026-07-20	SCHEDULE 13G	CVI Investments, Inc.	—	—	view →
2026-07-10	SCHEDULE 13D	ALAFI CAPITAL CO LLC	17.10%	5,242,996	view →
2026-07-02	SCHEDULE 13D	Bering Partners II GP, L.L.C.	6.90%	2,113,513	view →
2026-06-30	SCHEDULE 13D/A	Valence Investments SPV VI, LLC	—	356,989	view →
2023-05-23	SC	Flynn James E	—	—	view →

Other Filings by ORBIMED ADVISORS LLC

Filed	Form	Issuer	Stake	Shares
2026-08-10	SCHEDULE 13D/A	MBX Biosciences, Inc.	—	3,074,853	view →
2026-08-05	SCHEDULE 13D	Yarrow Bioscience, Inc.	9.97%	266,306	view →
2026-07-29	SCHEDULE 13D	Scribe Therapeutics, Inc.	7.20%	1,348,825	view →
2026-07-20	SCHEDULE 13D/A	Q32 Bio Inc.	—	4,127,987	view →
2026-06-24	SCHEDULE 13D/A	Enliven Therapeutics, Inc. ELVN	—	6,774,507	view →
2026-06-17	SCHEDULE 13D/A	Enliven Therapeutics, Inc. ELVN	10.93%	7,634,630	view →
2026-06-15	SCHEDULE 13D/A	Shattuck Labs, Inc. STTK	—	9,021,127	view →
2026-06-01	SCHEDULE 13D/A	Q32 Bio Inc. QTTB	—	4,127,987	view →
2026-04-10	SCHEDULE 13D/A	Adicet Bio, Inc. ACET	8.80%	844,787	view →
2026-01-27	SCHEDULE	Corvus Pharmaceuticals, Inc. CRVS	10.30%	8,609,091	view →
2025-10-10	SCHEDULE	Adicet Bio, Inc. ACET	9.60%	14,772,598	view →
2025-09-30	SCHEDULE	MBX Biosciences, Inc. MBX	9.00%	4,002,887	view →
2025-07-21	SCHEDULE	Passage BIO, Inc. PASG	7.82%	243,878	view →
2025-05-14	SCHEDULE	Corvus Pharmaceuticals, Inc. CRVS	12.20%	9,785,423	view →
2025-04-11	SCHEDULE	Compass Therapeutics, Inc. CMPX	11.00%	15,219,994	view →
2025-01-29	SCHEDULE	Traws Pharma, Inc. TRAW	19.90%	760,824	view →
2024-11-12	SC	Third Harmonic Bio, Inc.	—	—	view →
2024-10-25	SC	TELA Bio, Inc. TELA	—	—	view →
2024-10-01	SC	TELA Bio, Inc. TELA	—	—	view →
2024-07-02	SC	TELA Bio, Inc. TELA	—	—	view →

Showing 20 of 138

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →